US FDA and NIH heads outline plan for personalised medicine
This article was originally published in RAJ Devices
Executive Summary
The heads of the US Food and Drug Administration and the National Institutes of Health are working together to improve the approval process for companion diagnostics. They hope to establish a level of regulation that “both protects patients and encourages innovation”.